St. Francis' titanium implant sales strong

06/5/2006 | American City Business Journals

The FDA's recent approval of St. Francis Medical Technologies' titanium-alloy implant for lumbar spinal stenosis has meant surging U.S. sales for the privately held company. The company's president and CEO said he anticipates worldwide revenue of $30 million to $50 million this year, up from $11 million last year.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT